Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI \<40days, recent PCI/CABG \< 3months etc.). Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Study Type
OBSERVATIONAL
Enrollment
450
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Medical University of Graz/ Division of Cardiology
Graz, Austria
RECRUITINGNumber of participants treated with WCD-treated ventricular arrhythmias
Number of participants treated with WCD-treated ventricular arrhythmias
Time frame: during WCD wearing period; average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.